Unknown NA INTERVENTIONAL 1-arm NCT03223142

Standardization of Multi-modal Tumor Ablation Therapy System (SMTATS)

A Pilot Study of Multi-mode Precision Ablation System for the Treatment of Liver Malignant

Sponsor: Changhai Hospital

Conditions Ablation Techniques Clinical Trial Cryoablation Liver Neoplasms Neoplasm Metastasis Safety Treatment Outcome

Interventions Multi-modal Precision Ablation

Updated 6 times since 2017 Last updated: Jul 17, 2017 Started: Jul 31, 2017 Primary completion: Dec 31, 2019 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03223142, this NA trial focuses on Ablation Techniques and Clinical Trial and remains ongoing. Sponsored by Changhai Hospital, it has been updated 6 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA
Aug 2020 — Sep 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Aug 2017 — Aug 2020 [monthly]

Recruiting NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital
Fudan University
Ruijin Hospital
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai Zhongshan Hospital

Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China